Nexien BioPharma Inc logo

Nexien BioPharma Inc

NEW
OTCPK:NXEN (USA)  
$ 0.014 (0%) 07:08 PM EST
At Loss
Market Cap:
$ 991.00K
Enterprise V:
$ 1.34M
Volume:
-
Avg Vol (2M):
14.71K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
-
At Loss
Avg Vol (2M):
14.71K

Business Description

Description
Nexien BioPharma Inc is a U.S.-based pharmaceutical company engaged in the formulation, development and commercialization of cannabinoid-based pharmaceuticals, in accordance with U.S. Food and Drug Administration ('FDA') pre-clinical and clinical pathways.

Financial Strength

Name Current Vs Industry Vs History
Equity-to-Asset -423
Debt-to-Equity -0.83
Debt-to-EBITDA -2.93
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 60.7
3-Year EPS without NRI Growth Rate 48.9
3-Year FCF Growth Rate 20.6

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 96.74
9-Day RSI 84.06
14-Day RSI 71.23
3-1 Month Momentum % 27.27
6-1 Month Momentum % -59.77
12-1 Month Momentum % -76.51

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -8.1
Shareholder Yield % -8.24

Profitability Rank

Name Current Vs Industry Vs History
ROA % -3907.41
ROIC % -39.4
3-Year ROIIC % 564.55

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -11.18
EV-to-EBITDA -11.18
EV-to-FCF -19.16
Earnings Yield (Greenblatt) % -8.94
FCF Yield % -7.06

Financials

NXEN's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:NXEN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Nexien BioPharma Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.003
Beta -1.37
3-Year Sharpe Ratio 0.12
3-Year Sortino Ratio 0.22
Volatility % 210.19
14-Day RSI 71.23
14-Day ATR ($) 0.000571
20-Day SMA ($) 0.01054
12-1 Month Momentum % -76.51
52-Week Range ($) 0.0041 - 0.0495
Shares Outstanding (Mil) 70.77

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nexien BioPharma Inc Filings

Filing Date Document Date Form
No Filing Data

Nexien BioPharma Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Nexien BioPharma Inc Frequently Asked Questions

What is Nexien BioPharma Inc(NXEN)'s stock price today?
The current price of NXEN is $0.01. The 52 week high of NXEN is $0.05 and 52 week low is $0.00.
When is next earnings date of Nexien BioPharma Inc(NXEN)?
The next earnings date of Nexien BioPharma Inc(NXEN) is .
Does Nexien BioPharma Inc(NXEN) pay dividends? If so, how much?
Nexien BioPharma Inc(NXEN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1